Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...

In the case of SMA, administration of valproic acid and tobramycin showed an improvement in the biochemical characteristics of iPS cells, but it remains unclear whether such treatment also ...

Unlocking the potential of cancer immune-cell therapies Cancer immune-cell therapy using iPS-Ts has the potential to become a curative intervention for the treatment not only of myeloproliferative ...

the first being an iPS cell-based treatment of macular degeneration of the eye, which also took place in Japan.While it is a big deal to pioneer such a technology clinically, the trial also has its ...

The researchers will assess the efficacy of the novel therapy by examining the safety of the iPS-derived NKT cells and changes in the size of tumors in the subjects through CT scans.

"When we began this project, we wanted to understand why this design allowed certain leukemia cells to escape therapy. Once we understood that, we knew how to design our ALA-CART cells. What was ...